We got an all-access pass to a two-day MLB training session in Scottsdale, Arizona.
Data from up to 42 months of treatment reinforce lucerastat’s potential as a first-in-class oral substrate reduction therapy addressing key unmet needs across the Fabry populationThe company is ...
The Company remains FCF positive for the fiscal year, while delivering strong same-store sales growth and cementing its presence within the German medical cannabis market Canadian Cabana ...
Total revenue of $3.19 billion, down 1.0% YoY (down 4.3% on an organic basis)(1) Bookings of $3.6 billion, book to bill ratio of 1.12x EBIT margin of 5.6%, and ...
Uncovering the First Reforestation Project in the 19th-Century Brazilian Atlantic Rainforest: Insights from Wood Anatomy and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results